being and becoming in the world
As part of the 2019 Summer Meeting of the British Association for Psychopharmacology has organised a ‘Trainees’ Workshop’ chaired by Professor Jeremy Hall and with the following five speakers: I … Continue reading BAP: Trainees’ Workshop
The launch in the UK of Lurisidone began in August 2014. My previous post on Lurasidone (Latuda) which has now been marketed in the UK followed the financial interests of … Continue reading Lurasidone [Latuda]: vigorously marketed in the UK
I noticed this “Special Article” published in the October edition of the British Journal of Psychiatry. It details a novel antipsychotic medication called Lurasidone (trade name Latuda). I would anticipate … Continue reading Lurasidone: “Special Article”